AgingResearch.NewsJoin free

Toll Biotech

CompanyChina

Toll Biotech develops one asset, in phase 2 (TollB-001 in rheumatoid arthritis). Mostly small molecule acting on inflammation; based in China.

1
Asset
Furthest stage
Phase 2
1
Trial
0
Signals

Pipeline

1

  • TollB-001

    Oral chemical drug targeting innate immunity signaling in rheumatoid arthritis.

    Phase 2, Small molecule, Inflammation, rheumatoid arthritis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Signals1
  • Similar companies6

Intelligence